Prenatal Yoga Intervention in Pregnant Women
9 mei 2026 bijgewerkt door: Duygu Özer, PhD, Saglik Bilimleri Universitesi
Effects of a Prenatal Yoga Intervention on Traumatic Childbirth Perception, Self-Perception, and Delivery Preferences in Pregnant Women
The aim of this study is to determine the effects of a prenatal yoga intervention on traumatic childbirth perception, self-perception, and delivery preferences in pregnant women.
Studie Overzicht
Toestand
Werving
Interventie / Behandeling
Gedetailleerde beschrijving
This study will be conducted with voluntary pregnant women aged 18 years and older, at or beyond the 16th week of gestation, and without a diagnosis of high-risk pregnancy. Participants will be randomly assigned to the intervention and control groups using a computer-generated simple randomization method (https://www.random.org/integers/
) to ensure unbiased allocation. The intervention group will consist of 8-12 participants per group, and the program will be implemented in three separate groups. Participants in the intervention group will receive a prenatal yoga program consisting of eight sessions delivered twice weekly, while the control group will receive routine prenatal care without any additional intervention from the researchers. Data collection instruments will be administered at baseline (pre-test), at the end of the eighth session (post-test), and at a one-month follow-up.
Studietype
Ingrijpend
Inschrijving (Geschat)
46
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studiecontact
- Naam: Duygu Özer, Asst. Prof
- Telefoonnummer: +905061291978
- E-mail: duyguozer2016@hotmail.com
Studie Locaties
-
-
Bartın
-
Bartın, Bartın, Turkije (Türkiye), 74100
- Werving
- Bartın University
-
Contact:
- Duygu Özer, Asst. prof
- Telefoonnummer: +9 05061291978
- E-mail: duyguozer2016@hotmail.com
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Ja
Beschrijving
Inclusion Criteria:
- Being at or beyond the 16th week of gestation (second trimester or later)
- Being aged 18 years or older
- Having no diagnosis of high-risk pregnancy based on obstetric evaluation
- Having no medical restriction on physical activity or yoga practice as determined by a physician
- Providing written informed consent after being informed about the study
Exclusion Criteria:
- Diagnosis of high-risk pregnancy (e.g., preeclampsia, placenta previa, premature rupture of membranes, risk of preterm birth, or other serious obstetric complications)
- Physician-imposed restriction on physical activity
- Presence of serious systemic conditions that would prevent participation in yoga practice
- Inability to complete the questionnaires reliably due to psychiatric or cognitive conditions
- Declining to participate or not providing informed consent
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Experimental
Prenatal Yoga Program was applied to the intervention group.
|
Participants in the intervention group received a structured prenatal yoga program consisting of eight sessions delivered twice weekly.
Each session lasted approximately 45 minutes and was conducted in accordance with safe prenatal exercise guidelines.
|
|
Geen tussenkomst: Control
Participants in the control group received routine prenatal care only and were not exposed to any structured intervention during the study period.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Traumatic Childbirth Perception Scale
Tijdsspanne: Baseline, immediately after the 8-week intervention, and 1 month post-intervention
|
The Traumatic Childbirth Perception Scale is a self-report instrument designed to assess perceptions of traumatic childbirth, including physical, emotional, and psychological aspects.
The scale consists of 13 items.
Each item is rated on a scale ranging from 0 to 10, and total scores range from 0 to 130, with higher scores indicating higher levels of perceived traumatic childbirth.
Mean total scores are used to interpret the level of traumatic childbirth perception.
The score ranges are categorized as follows: 0-26 (very low), 27-52 (low), 53-78 (moderate), 79-104 (high), and 105-130 (very high).
|
Baseline, immediately after the 8-week intervention, and 1 month post-intervention
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Pregnant Women's Self-Perception Scale
Tijdsspanne: Baseline, immediately after the 8-week intervention, and 1 month post-intervention
|
The scale consists of 12 items rated on a 4-point Likert scale ranging from 1 (never) to 4 (always).
It comprises two subscales: maternal perception related to pregnancy (7 items) and body perception during pregnancy (5 items).
Higher scores on the maternal perception subscale (range: 7-28) indicate higher levels of positive maternal perception.
In contrast, higher scores on the body perception subscale (range: 5-20) reflect more negative body perception during pregnancy.
|
Baseline, immediately after the 8-week intervention, and 1 month post-intervention
|
|
Preferred Mode of Delivery Scale for Pregnant Women
Tijdsspanne: Baseline, immediately after the 8-week intervention, and 1 month post-intervention
|
The scale is suitable for women without systemic or psychiatric disorders and who conceived naturally.
It consists of 18 items and three subscales: self-efficacy, normative beliefs, and preferences.
Items are rated on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree).
Items 6-14 and 16-18 are reverse scored.
The total score is calculated by summing all item responses, and subscale scores can be obtained by summing the corresponding items.
The scale does not have a cut-off point.
Total scores range from 18 to 90, with higher scores indicating a stronger preference for vaginal delivery, as all items are scored in favor of vaginal birth for ease of interpretation.
|
Baseline, immediately after the 8-week intervention, and 1 month post-intervention
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Sponsor
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start (Geschat)
15 mei 2026
Primaire voltooiing (Geschat)
30 september 2026
Studie voltooiing (Geschat)
30 december 2026
Studieregistratiedata
Eerst ingediend
2 mei 2026
Eerst ingediend dat voldeed aan de QC-criteria
9 mei 2026
Eerst geplaatst (Werkelijk)
14 mei 2026
Updates van studierecords
Laatste update geplaatst (Werkelijk)
14 mei 2026
Laatste update ingediend die voldeed aan QC-criteria
9 mei 2026
Laatst geverifieerd
1 mei 2026
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- BARU-SBF-DO-4
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
NEE
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Nee
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Nee
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .